Metabolix, Inc.
Metabolix, Inc. is listed today as Yield10 Bioscience, Inc.: market value, financials and filings are on its company page.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2017 | $2 M | No. 2 | $2 to $10 million | equity, options | SEC | |
| Aug 2014 | $25 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Metabolix, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2017).
SEC Form D · Jul 2017
The industry group it chose in its notices: Other.
SEC Form D · Jul 2017
That is all the official record says: Metabolix, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Metabolix, Inc. are on record.
Investors#
6 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Birchview Capital GP, LLC | Fund or asset manager | not stated | not stated | Held Series B preferred stock, director (Form 3, 2014) | SEC Form 3 |
| Birchview Capital, LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, director (Form 3, 2014) | SEC Form 3 |
| Birchview Fund LLC | Fund or asset manager | not stated | not stated | Held Series B preferred stock, director (Form 3, 2014) | SEC Form 3 |
| Birchview Partners, LLC | Fund or asset manager | not stated | not stated | Held Series B preferred stock, director (Form 3, 2014) | SEC Form 3 |
| Schuler Family Foundation | Other | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| William P. Scully | Person | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 27 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Charles B. Haaser | Executive officer | Jul 2017 |
| Kristi D. Snell | Executive officer | Jul 2017 |
| Lynne H. Brum | Executive officer | Jul 2017 |
| Oliver P. Peoples | Executive officer | Jul 2017 |
| Johan D. van Walsem | Chief Operating Officer | Sep 2014 |
| Joseph D. Hill | Chief Financial Officer and Treasurer | Sep 2014 |
| Joseph Shaulson | President, Chief Executive Officer and Director | Sep 2014 |
| Lynne D. Brum | Vice President, Marketing and Corporate Communications | Sep 2014 |
| Sarah P. Cecil | General Counsel and Secretary | Sep 2014 |
| Anthony J. Sinskey | Director | Jul 2017 |
| Joseph N. Shaulson | Director | Jul 2017 |
| Oliver P. Peoples | Director | Jul 2017 |
| Peter N. Kellogg | Director | Jul 2017 |
| Richard W. Hamilton | Director | Jul 2017 |
| Robert L. Van Nostrand | Director | Jul 2017 |
| Celeste N. Beeks Mastin | Director | Sep 2014 |
| Joseph Shaulson | President, Chief Executive Officer and Director | Sep 2014 |
| Matthew J. Strobeck | Director | Sep 2014 |
About
American company.